Visit Competitors to Danuglipron Danuglipron, though not yet approved by the FDA, is part of a new class of weight loss drugs called GLP-1 receptor agonists
Some compounding pharmacies, medical spas, weight loss centers and wellness clinics have turned to making compounded versions of these drugs as a result of the shortages, which are not FDA-approved and potentially harmful
When stomach emptying slows, alcohol absorption becomes more gradual, which can either delay intoxication onset or create unpredictable blood alcohol levels depending on food intake and individual metabolism
Reisdorf recommends consulting with your health care provider when you're ready to restart your GLP-1
It could be more of a tightness or squeezing in your chest (or it could feel like outright pain), says Ethan Korngold, M.D., chief medical officer at Abbott 's vascular business